MedTrace Logo

Validation of Brain Function Assessment Algorithm for mTBI/Concussion in College Athletes

NCT02957461 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 420

Last updated 2019-05-23

No results posted yet for this study

Summary

This study is Part 1 of data collection from 18-25 years old subject population for validation of previously derived algorithms. This data will be combined with that collected under NCT03671083 (Part 2 with subject age range 13-25 years) for the final analyses of validation of the algorithms.

Conditions

  • Brain Injuries, Traumatic
  • Concussion, Mild
  • Concussion, Brain
  • Concussion, Severe
  • Concussion, Intermediate

Interventions

DEVICE

BrainScope Ahead 200iD

The BrainScope Battery evaluation will consist of 4 tests to aid in the assessment of concussion: History, Physical, signs and symptoms (SAC, SCAT3), Electrophysiological Function; Neurocognitive Performance Assessment and Ocular Motor assessment. BrainScope Ahead 200iD device will be used to perform EEG.

Sponsors & Collaborators

  • United States Department of Defense

    collaborator FED

  • BrainScope Company, Inc.

    lead INDUSTRY

Principal Investigators

  • Leslie Prichep, Ph.D. · BrainScope Company, Inc.

Eligibility

Min Age
18 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-03
Primary Completion
2018-01-31
Completion
2018-03-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02957461 on ClinicalTrials.gov